Market Research Logo

The Global Market for Stem Cells

The Global Market for Stem Cells

The global stem cell market reached over $5.9 billion in 2015 and will grow from about $6.7 billion in 2016 to nearly $12.3 billion in 2021, registering a compound annual growth rate (CAGR) of 13.1% from 2016 through 2021.

This report provides:
An overview of the global market for stem cells and related technologies
Analyses of global market trends, with data from 2014, 2015, estimates for 2016 and projections of compound annual growth rates (CAGRs) through 2021
Information on the implications of stem cell research and commercial trends in the context of the current size and growth of the pharmaceutical market
A look at the regulatory environment, healthcare policies, demographics, and other factors directly affecting stem cell-related markets
Analysis of the market's dynamics, specifically growth drivers, restraints, and opportunities
Examination of strategies employed by companies specializing in this field to meet the challenges of a competitive and fast-growing market
Profiles of major players in the industry


SCOPE OF REPORT

This report discusses the implications of stem cell research and commercial trends in the context of the current size and growth of the pharmaceutical market, both in global terms and analyzed by the most important national markets. The important technologies supporting stem cells are reviewed, and the nature and structure of the stem cell industry is discussed with profiles of the leading companies, including recent M&A activity. Five-year sales forecasts are provided for the national markets and the major therapeutic categories of products involved.

CHAPTER 1 INTRODUCTION
STUDY GOALS AND OBJECTIVES
REASONS FOR DOING THE STUDY
SCOPE OF REPORT
MARKET ANALYSES AND FORECASTS
METHODOLOGY
INTENDED AUDIENCE
INFORMATION SOURCES
ANALYST'S CREDENTIALS
RELATED BCC RESEARCH REPORTS
BCC RESEARCH WEBSITE
DISCLAIMER
CHAPTER 2 SUMMARY
DEFINITIONS
APPLICATIONS
RESEARCH AND COMMERCIALIZATION
FUNDING
MARKET
SUMMARY TABLE GLOBAL STEM CELL MARKET BY REGION, THROUGH 2021 ($ MILLIONS)
SUMMARY FIGURE GLOBAL STEM CELL MARKET BY REGION, 2014-2021 ($ MILLIONS)
CHAPTER 3 OVERVIEW
CELLS
STEM CELLS
FIGURE 1 EARLY DEVELOPMENT OF EMBRYO
INDUCED PLURIPOTENT STEM CELLS
Mesenchymal Stem Cells
hpSCS
THE CANCER PROBLEM
CANCER STEM CELLS-A WIDER TOPIC
CHAPTER 4 STEM CELL RESEARCH
HISTORY
EMBRYONIC STEM CELLS
Growth and Identification of ESCs
Stimulating ESCs to Differentiate
NEW CELL LINE
ADULT STEM CELLS
Mesenchymal Stem Cells (MSCs)
Hematopoietic Stem Cells (HSCs)
Neural Stem Cells (NSCs)
Endothelial Progenitor Cells (EPCs)
Epithelial Stem Cells (ESCs)
Very Small Embryonic-Like Cells (VSELs)
CORD BLOOD STEM CELLS
INDUCED PLURIPOTENT STEM CELLS (IPSCS)
Nuclear Reprogramming
CELL-BASED THERAPEUTICS
EMBRYONIC-DERIVED STEM CELLS
ADULT/PROGENITOR-DERIVED STEM CELLS
ENGINEERED SCS FOR TRANSPLANTATION
THERAPEUTIC STEM CELL BANKING
STEM CELL-BASED BIOMEDICAL RESEARCH
REGULATION OF STEM CELL RESEARCH
NATIONAL REGULATORY MEASURES
Australia
Brazil
Canada
China
France
Germany
India
Ireland
Israel
Italy
Japan
South Korea
Spain
Sweden
United Kingdom
United States
California
Massachusetts
Michigan
New Jersey
New York
FDA Approach
EUROPEAN UNION
PRACTICALITIES OF STEM CELL RESEARCH AND PRODUCTION
STEM CELL PRODUCTION
STEM CELL ACQUISITION
Characterization and Expansion
Maintenance and Storage
STEM CELL PRODUCTION ECONOMICS
Customized Therapy
Banks
NOVEL STEM CELL PRODUCTION DEVELOPMENTS
ISOLATION AND ENGINEERING
Adult Stem Cells
Embryonic Stem Cells
Induced Pluripotent Stem Cells
STEM CELL BANKING
ISCBI PROJECT
TABLE 1 COUNTRIES ENGAGED IN THE ISCBI PROGRAM
FUTURE PERSPECTIVE: THE RISE OF THE ORGANOIDS
CHAPTER 5 STEM CELL APPLICATIONS
REGENERATIVE MEDICINE
CURRENT APPLICATIONS OF STEM CELL THERAPY
CANCER
Hematopoiesis (Blood Cell Formation)
AMYOTROPHIC LATERAL SCLEROSIS
PARKINSON'S DISEASE
SPINAL CORD INJURY
ALZHEIMER'S DISEASE
STROKE
HEART DISEASE
Doubts Expressed
PERIPHERAL ARTERIAL DISEASE
TYPE 1 DIABETES
ORTHOPEDIC REPAIR
LIVER FAILURE
GRAFT-VERSUS-HOST DISEASE
LUNG DISEASE
STATUS OF STEM CELL CLINICAL TRIALS
Prochymal-stem Cell Therapy
Prochymal-Crohn's Disease and Gastrointestinal Injury from Radiation
Mesenchymal Precursor Cell (MPC) Product-Stem Cell Therapy (Orphan Drug)
MyoCell-Stem Cell Therapy
ixmyelocel-T-Stem Cell Therapy (Fast Track)
StemEx (carlecortemcel-L)-Stem Cell Therapy (Orphan Drug) (Fast Track)
GSK 2696273-Stem Cell Therapy
Adult Autologous Stem Cell Therapy (Renew)-Stem Cell Therapy
CHAPTER 6 STEM CELL PATENTS
GENERAL BACKGROUND ON PATENTS
STEM CELL PATENTS
PATENTABILITY OF STEM CELL LINES
INDIVIDUAL COUNTRY POLICIES
UNITED STATES
CANADA
EPC
UNITED KINGDOM
GERMANY
JAPAN
CHINA
iPS Cells
TABLE 2 IPS-RELATED PATENTS (YAMANAKA, 2011)
TABLE 3 CLASSIFICATION OF STEM CELL PATENTS
CHAPTER 7 STEM CELL MARKETS
MARKETS FOR STEM CELLS
MARKET DRIVERS
Healthcare
TABLE 4 HEALTHCARE SYSTEMS OF DIFFERENT COUNTRIES
Market Restraints
Biotechnology
Pharmaceutical
MARKET OPPORTUNITIES BY THERAPEUTIC CLASS
CANCER
Other Cancers
CARDIOVASCULAR DISEASE
Myocardial Infarction
TABLE 5 EXAMPLES OF COMPANIES DEVELOPING STEM CELL
THERAPIES FOR CVD
CENTRAL NERVOUS SYSTEM DISEASE
Spinal Cord Injury (SCI)
TABLE 6 STATISTICS FOR SCI IN THE U.S., 2014
Neurodegenerative Diseases
TABLE 7 NEURODEGENERATIVE DISEASES WORLDWIDE, 2015
DIABETES MELLITUS
TABLE 8 STATISTICS FOR DIABETES IN THE U.S., 2014
TABLE 9 GLOBAL MARKET FOR DIABETES MELLITUS TREATMENTS AND DEVICES, THROUGH 2021 ($ BILLIONS)
SKELETAL SYSTEM
GLOBAL MARKET ESTIMATES AND FORECASTS
TABLE 10 GLOBAL STEM CELL MARKET BY REGION, THROUGH 2021 ($ MILLIONS)
REGIONAL AND NATIONAL MARKET ANALYSIS
AMERICAS
TABLE 11 AMERICAS STEM CELL MARKET BY COUNTRY, THROUGH 2021 ($ MILLIONS)
U.S.
TABLE 12 POTENTIAL U.S. PATIENT POPULATIONS FOR CELL-BASED
THERAPIES
TABLE 13 U.S. STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS)
TABLE 14 U.S. STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
TABLE 15 U.S. STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
Canada
TABLE 16 CANADA STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS)
TABLE 17 CANADA STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
TABLE 18 CANADA STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
Brazil
TABLE 19 BRAZIL STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS)
TABLE 20 BRAZIL STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
TABLE 21 BRAZIL STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
Mexico
TABLE 22 MEXICO STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS)
TABLE 23 MEXICO STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
EUROPE
TABLE 24 EUROPE STEM CELL MARKET BY COUNTRY, THROUGH 2021 ($ MILLIONS)
Market Opportunities by Disease Category
TABLE 25 STATISTICS FOR CVD IN EUROPE, 2012
TABLE 26 RATE OF DEATH FROM HEART DISEASE IN DIFFERENT EUROPEAN COUNTRIES, 2012 (NO. OF DEATHS PER 100,000 CASES)
TABLE 27 STATISTICS FOR CNS DISORDERS AND INJURIES IN EUROPE, 2013
TABLE 28 STATISTICS FOR SCI AND PARKINSON'S DISEASE IN DIFFERENT EUROPEAN COUNTRIES, 2011
TABLE 29 PREVALENCE OF DIABETIC PATIENTS IN DIFFERENT EUROPEAN COUNTRIES, 2013
France
TABLE 30 FRANCE STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS)
TABLE 31 FRANCE STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
TABLE 32 FRANCE STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
Germany
TABLE 33 GERMANY STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS)
TABLE 34 GERMANY STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
TABLE 35 GERMANY STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
Italy
TABLE 36 ITALY STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS)
TABLE 37 ITALY STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
TABLE 38 ITALY STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
Spain
TABLE 39 SPAIN STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS)
TABLE 40 SPAIN STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
TABLE 41 SPAIN STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
United Kingdom
TABLE 42 U.K. STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS)
TABLE 43 U.K. STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
TABLE 44 U.K. STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
ASIA
Market Opportunities by Disease Category
TABLE 45 STATISTICS FOR CVD IN DIFFERENT REGIONS OF THE WORLD, 2011
TABLE 46 EXAMPLES OF STEM CELL POLICIES IN ASIAN COUNTRIES
TABLE 47 ASIA STEM CELL MARKET BY COUNTRY, THROUGH 2021 ($ MILLIONS)
Japan
TABLE 48 JAPAN STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS)
TABLE 49 JAPAN STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
TABLE 50 JAPAN STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
China
TABLE 51 CHINA STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS)
TABLE 52 CHINA STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
TABLE 53 CHINA STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
India
TABLE 54 POTENTIAL CANDIDATES FOR STEM CELL THERAPY IN INDIA
TABLE 55 INDIA STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS)
TABLE 56 INDIA STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
TABLE 57 INDIA STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($ MILLIONS)
REST OF WORLD
TABLE 58 REST OF WORLD STEM CELL MARKET BY SEGMENT, THROUGH 2021 ($ MILLIONS)
CHAPTER 8 COMPANY PROFILES
3DMATRIX
ALDAGEN INC.
ANGIOBLAST SYSTEMS
ARTERIOCYTE
ATHERSYS INC.
BEIKE BIOTECHNOLOGY CO. LTD.
BIOTIME INC.
BRAINSTORM CELL THERAPEUTICS INC.
CALADRIUS BIOSCIENCES INC.
CAPRICOR INC.
CELLERANT THERAPEUTICS INC.
CELLERIX SA
CELLULAR DYNAMICS INTERNATIONAL
CELYAD
CLONTECH
CYTORI THERAPEUTICS INC.
EPISTEM LTD.
GAMIDA CELL LTD.
GLOBALSTEM
HYBRID ORGAN GMBH
INTELLICELL BIOSCIENCES INC.
INTERNATIONAL STEM CELL CORP.
JUVENTAS THERAPEUTICS INC.
MESOBLAST LTD.
NEURALSTEM
NEUROGENERATION
OCATA
OSIRIS THERAPEUTICS INC.
PRIMEGEN BIOTECH LLC
RENEURON GROUP
RHINOCYTE INC.
STEM CELLS INC.
STEMCELL TECHNOLOGIES SARL
STEM CELL THERAPEUTICS CORP.
STEMEDICA CELL TECHNOLOGIES INC.
STEMINA BIOMARKER DISCOVERY INC.
STEMPEUTICS RESEARCH PVT. LTD.
TIGENIX NV
U.S. STEM CELL
VERASTEM INC.
VERICEL
VERISTEM TECHNOLOGIES
VIACYTE
VITRO DIAGNOSTICS INC.
WICELL RESEARCH INSTITUTE
XPAND BIOTECHNOLOGY BV
CHAPTER 9 GLOSSARY
CHAPTER 10 SIGNIFICANT STEM CELL RESEARCH PATENTS
TABLE 59 SIGNIFICANT STEM CELL RESEARCH PATENTS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report